QuidelOrtho Price to Sales Ratio 2010-2023 | QDEL
Historical PS ratio values for QuidelOrtho (QDEL) over the last 10 years. The current P/S ratio for QuidelOrtho as of April 19, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| QuidelOrtho P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-19 | 39.12 | 0.87 | |
| 2023-12-31 | 73.70 | $44.80 | 1.64 |
| 2023-09-30 | 73.04 | $48.78 | 1.50 |
| 2023-06-30 | 82.86 | $49.27 | 1.68 |
| 2023-03-31 | 89.09 | $50.91 | 1.75 |
| 2022-12-31 | 85.67 | $61.94 | 1.38 |
| 2022-09-30 | 71.48 | $61.69 | 1.16 |
| 2022-06-30 | 97.18 | $62.08 | 1.57 |
| 2022-03-31 | 112.46 | $54.64 | 2.06 |
| 2021-12-31 | 134.99 | $39.63 | 3.41 |
| 2021-09-30 | 141.15 | $43.34 | 3.26 |
| 2021-06-30 | 128.12 | $42.27 | 3.03 |
| 2021-03-31 | 127.93 | $42.71 | 3.00 |
| 2020-12-31 | 179.65 | $38.12 | 4.71 |
| 2020-09-30 | 219.38 | $23.09 | 9.50 |
| 2020-06-30 | 223.74 | $15.09 | 14.82 |
| 2020-03-31 | 97.81 | $13.09 | 7.47 |
| 2019-12-31 | 75.03 | $12.52 | 5.99 |
| 2019-09-30 | 61.35 | $12.10 | 5.07 |
| 2019-06-30 | 59.32 | $11.91 | 4.98 |
| 2019-03-31 | 65.47 | $12.02 | 5.45 |
| 2018-12-31 | 48.82 | $12.61 | 3.87 |
| 2018-09-30 | 65.17 | $12.90 | 5.05 |
| 2018-06-30 | 66.50 | $11.66 | 5.70 |
| 2018-03-31 | 51.81 | $10.08 | 5.14 |
| 2017-12-31 | 43.35 | $8.22 | 5.28 |
| 2017-09-30 | 43.86 | $6.43 | 6.83 |
| 2017-06-30 | 27.14 | $6.43 | 4.22 |
| 2017-03-31 | 22.64 | $6.49 | 3.49 |
| 2016-12-31 | 21.42 | $5.86 | 3.65 |
| 2016-09-30 | 22.09 | $5.79 | 3.82 |
| 2016-06-30 | 17.86 | $5.67 | 3.15 |
| 2016-03-31 | 17.26 | $5.48 | 3.15 |
| 2015-12-31 | 21.20 | $5.67 | 3.74 |
| 2015-09-30 | 18.88 | $6.01 | 3.14 |
| 2015-06-30 | 22.95 | $5.82 | 3.94 |
| 2015-03-31 | 26.98 | $5.72 | 4.72 |
| 2014-12-31 | 28.92 | $5.36 | 5.40 |
| 2014-09-30 | 26.87 | $4.97 | 5.41 |
| 2014-06-30 | 22.11 | $4.76 | 4.65 |
| 2014-03-31 | 27.30 | $4.72 | 5.78 |
| 2013-12-31 | 30.89 | $5.15 | 6.00 |
| 2013-09-30 | 28.40 | $5.26 | 5.40 |
| 2013-06-30 | 25.53 | $5.27 | 4.84 |
| 2013-03-31 | 23.75 | $5.33 | 4.46 |
| 2012-12-31 | 18.67 | $4.67 | 4.00 |
| 2012-09-30 | 18.93 | $4.22 | 4.48 |
| 2012-06-30 | 15.68 | $4.22 | 3.71 |
| 2012-03-31 | 18.37 | $4.12 | 4.45 |
| 2011-12-31 | 15.13 | $4.81 | 3.14 |
| 2011-09-30 | 16.37 | $4.77 | 3.43 |
| 2011-06-30 | 15.15 | $4.77 | 3.18 |
| 2011-03-31 | 11.96 | $4.81 | 2.48 |
| 2010-12-31 | 14.45 | $3.99 | 3.62 |
| 2010-09-30 | 10.99 | $5.08 | 2.16 |
| 2010-06-30 | 12.69 | $5.94 | 2.14 |
| 2010-03-31 | 14.54 | $5.88 | 2.47 |
| 2009-12-31 | 13.78 | $5.43 | 2.54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.559B | $2.998B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.663B | 23.98 |
| Stryker (SYK) | United States | $124.585B | 30.89 |
| Medtronic (MDT) | Ireland | $105.150B | 14.89 |
| Boston Scientific (BSX) | United States | $98.912B | 32.89 |
| EssilorLuxottica (ESLOY) | France | $98.803B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.442B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.123B | 29.04 |
| ResMed (RMD) | United States | $26.124B | 26.12 |
| Terumo (TRUMY) | Japan | $24.607B | 34.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.518B | 15.78 |
| Baxter (BAX) | United States | $20.135B | 14.69 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.535B | 60.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.496B | 0.00 |
| Demant (WILYY) | Denmark | $9.782B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.014B | 23.88 |
| BellRing Brands (BRBR) | United States | $7.103B | 38.19 |
| Lantheus Holdings (LNTH) | United States | $4.273B | 11.03 |
| Haemonetics (HAE) | United States | $4.239B | 21.68 |
| Perrigo (PRGO) | Ireland | $4.057B | 11.60 |
| GN Store Nord (GNNDY) | Denmark | $3.581B | 23.19 |
| Envista Holdings (NVST) | United States | $3.394B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.394B | 16.05 |
| Green Thumb Industries (GTBIF) | United States | $2.720B | 86.20 |
| Neogen (NEOG) | United States | $2.584B | 24.85 |
| ICU Medical (ICUI) | United States | $2.361B | 17.62 |
| TG Therapeutics (TGTX) | United States | $2.160B | 699.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.913B | 0.00 |
| Owens & Minor (OMI) | United States | $1.843B | 17.69 |
| Verano Holdings (VRNOF) | United States | $1.841B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.654B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.466B | 45.66 |
| InMode (INMD) | Israel | $1.456B | 7.54 |
| LeMaitre Vascular (LMAT) | United States | $1.406B | 46.38 |
| AdaptHealth (AHCO) | United States | $1.244B | 9.36 |
| Warby Parker (WRBY) | United States | $1.169B | 0.00 |
| AtriCure (ATRC) | United States | $1.131B | 0.00 |
| MacroGenics (MGNX) | United States | $1.005B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.713B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.84 |
| Evolus (EOLS) | United States | $0.670B | 0.00 |
| Jin Medical (ZJYL) | China | $0.617B | 0.00 |
| Quanterix (QTRX) | United States | $0.604B | 0.00 |
| Valneva SE (VALN) | France | $0.565B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.528B | 11.44 |
| TerrAscend (TSNDF) | Canada | $0.507B | 0.00 |
| PetIQ (PETQ) | United States | $0.472B | 17.61 |
| ZimVie (ZIMV) | United States | $0.427B | 26.13 |
| Biote (BTMD) | United States | $0.405B | 3.86 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Surmodics (SRDX) | United States | $0.376B | 40.60 |
| Zynex (ZYXI) | United States | $0.368B | 42.41 |
| Aurora Cannabis (ACB) | Canada | $0.356B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.302B | 30.00 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.71 |
| Veru (VERU) | United States | $0.208B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 21.55 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
| InterCure (INCR) | Israel | $0.118B | 19.92 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.104B | 0.00 |
| Safety Shot (SHOT) | United States | $0.099B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.18 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |